Elisabeth Crönert-Bendell
Corporate Officer/Principal en RHYTHM PHARMACEUTICALS, INC. .
Cargos activos de Elisabeth Crönert-Bendell
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
RHYTHM PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/04/2021 | - |
Historial de carrera de Elisabeth Crönert-Bendell
Antiguos cargos conocidos de Elisabeth Crönert-Bendell.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
SANOFI | Corporate Officer/Principal | - | - |
Kyowa Kirin International Plc
Kyowa Kirin International Plc Pharmaceuticals: MajorHealth Technology Kyowa Kirin International Plc is a specialty pharmaceutical company, which engages in the development and commercialization of prescription medicines for the treatment of unmet therapeutic needs in major markets. It offers Sancuso, a prescription medicine used to prevent nausea and vomiting in people receiving some types of chemotherapy treatment and Abstral, a medicine used in the management of breakthrough pain in adult patients using opioid therapy for chronic cancer pain. The company was founded in 1995 and is headquartered in Galashiels, the United Kingdom. | Corporate Officer/Principal | - | - |
Formación de Elisabeth Crönert-Bendell.
INSEAD | Masters Business Admin |
Estadísticas
Internacional
Francia | 3 |
Estados Unidos | 2 |
Reino Unido | 2 |
Operativa
Corporate Officer/Principal | 3 |
Masters Business Admin | 1 |
Sectorial
Health Technology | 4 |
Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
RHYTHM PHARMACEUTICALS, INC. | Health Technology |
SANOFI | Health Technology |
Empresas privadas | 1 |
---|---|
Kyowa Kirin International Plc
Kyowa Kirin International Plc Pharmaceuticals: MajorHealth Technology Kyowa Kirin International Plc is a specialty pharmaceutical company, which engages in the development and commercialization of prescription medicines for the treatment of unmet therapeutic needs in major markets. It offers Sancuso, a prescription medicine used to prevent nausea and vomiting in people receiving some types of chemotherapy treatment and Abstral, a medicine used in the management of breakthrough pain in adult patients using opioid therapy for chronic cancer pain. The company was founded in 1995 and is headquartered in Galashiels, the United Kingdom. | Health Technology |